MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A case of severe blepharospasm after psoralen and ultraviolet A treatment

P. Ferreira, S. Moreira (Senhora da Hora, Portugal)

Meeting: 2019 International Congress

Abstract Number: 1273

Keywords: Blepharospasm

Session Information

Date: Tuesday, September 24, 2019

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: Report a case of blepharospasm secondary to PUVA therapy

Background: Blepharospasm is a focal dystonia that can present as spasms of the eyelids, involuntary eyes’ closure, enhanced spontaneous blinking or any combination of these. Primary blepharospasm usually starts in adulthood and is the most frequent type. Its secondary form has been described in cases of structural brain lesions, prolonged exposure to certain drugs and neurodegenerative diseases, such as parkinsonian syndromes. Although it has been described as a presenting symptom of photokeratitis, it has never been associated with other forms of structural or iatrogenic ocular lesions, such as psoralen and ultraviolet A (PUVA) therapy.

Method: Retrospective analysis of the patient’s’ clinical registries

Results: A 50 years old woman, with a past medical history of psoriatic arthritis, presented to our emergency department in 2002 complaining of sudden blurred vision and headache worsened by eye movements and accompanied with phono and photophobia. A month before she had been subjected to PUVA for psoriatic lesions and developed severe and extensive burn injuries all over her body. Neurological examination was striking for diminished pupillary reflex in the right eye, complex gaze ophthalmoplegia and enhanced blinking. In the following appointments she kept the enhanced blinking and severe photophobia with a permanent need for orange filter glasses, even in the dark. Without them she is functionally blind and the eyes are in permanent supraversion. She has been treated with botulinum toxin, with improvement of the blepharospasm.

Conclusion: Blepharospasm is a rare dystonia much more common in it’s primary form. Even though it has already been described as a secondary form of numerous etiologies, this is the first case report of blepharospasm after PUVA, presenting in a severe and disabling way.

To cite this abstract in AMA style:

P. Ferreira, S. Moreira. A case of severe blepharospasm after psoralen and ultraviolet A treatment [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/a-case-of-severe-blepharospasm-after-psoralen-and-ultraviolet-a-treatment/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-case-of-severe-blepharospasm-after-psoralen-and-ultraviolet-a-treatment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley